Amneal Tells Fed Circ. Endo Played With Numbers In Patent
Amneal Pharmaceuticals LLC renewed its push Monday to persuade the Federal Circuit to reverse a Patent Trial and Appeal Board ruling that prior art didn't make Endo Pharmaceuticals Inc.'s patents for...To view the full article, register now.
Already a subscriber? Click here to view full article